Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant — Stella
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(10 sites) United States
Children's Hospital of Los Angeles, Los Angeles, California Children's National Medical Center, Washington D.C., District of Columbia Children's Healthcare of Atlanta, Atlanta, Georgia University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa Dana Farber / Boston Children's Hospital, Boston, Massachusetts UH Rainbow Babies and Children's Hospital (University Hospitals Cleveland Medical Center), Cleveland, Ohio Cleveland Clinic Foundation, Cleveland, Ohio Oregon Health and Science University, Portland, Oregon Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington
Key details Sponsor
Fred Hutchinson Cancer Center
Collaborators
National Cancer Institute (NCI)
Enrollment target
~68 participants
Primary completion
December 2027
Last updated October 2025